Resource id #3DrugId:2d00000015resource(4) of type (mysql result) Drug Search

Main    A    B    C    D    E    F    G    H    I    J    K    L    M    N    O    P    Q    R    S    T    U    V    W    X    Y    Z    Main   

Drug ID: 2d00000015

Drug Name: Belladona/Ergotamine/Phenobarbital

Generic Names: Ergophen | Bellamine-S | Bellaspas | Bellergal-S

Category: Analgesics

Legal Status: Restricted Prescription only drug


Indication for Mother: Category X
Studies in animals or humans have demonstrated fetal abnormalities and/or there is positive evidence of human fetal risk based on adverse reaction data from investigational or marketing experience, and the risks involved in use of the drug in pregnant women clearly outweigh potential benefits.

Recommended Dose: Adults: 1 tablet in morning and evening.

Max: 16 tablets per week.

Recommended In: This medication contains Belladonna/Ergotamine/Phenobarbital, which are anticholinergic, barbiturate, and ergot agents. It is prescribed for nervousness and tension that falls under menopausal symptoms. This medication is also prescribed for treating heart/blood vessel disorder, stomach disorder and headache. The medication blocks certain chemicals in the nervous system thereby helps to relieve the signs and symptoms.

Directions For Use: It comes as a tablet to take by mouth, two times per day with or without food.

Storage: Store it at controlled room temperature (25C), and in an airtight container. Keep away from children and pets.

Dosage Forms: Tablet

Side Effects: Heart- Palpitations and fast heart rate.

Skin - Skin rash, itching, redness, blistering and hives.

Respiratory - Chest pain and tightness.

Central nervous system- Drowsiness and dizziness.

Eye and ENT- Blurred vision.

Gastrointestinal- Nausea, dry mouth and indigestion.

Genitourinary- Urinary retention.

Miscellaneous- Tingling, decreased sweating, cold hands, feet and sweating of face, lips and tongue region.

In Case of Overdose: If overdose is suspected, contact a poison control center or emergency room immediately.

Avoid If: Contraindicated in patients with preexisting heart disease, easy bruising, increased eye pressure, concomitant treatment with vasoconstrictor, administration with dopamine, pregnancy and known hypersensitivity.

Caution should be exercised in patients with history of poor blood circulation, high blood pressure, stroke, high cholesterol, gall bladder problems, liver and kidney disease, severe infection, allergy, myasthenia gravis, mental disorder, pregnancy and lactation.

It may cause blurred vision, dizziness, do not drive a car or operate machinery while taking this medication.

Avoid alcoholic beverages.

Heatstroke may occur, avoid strong sunlight.

Drug Interaction: Some products that may interact with this drug include: antispasmodics (e.g., atropine, dicyclomine), certain antiarrhythmic drugs (e.g., quinidine, procainamide), certain beta blockers (e.g., propranolol), certain drugs for Parkinson's disease (e.g., levodopa, benztropine, trihexyphenidyl), cyclosporine, disulfiram, dopamine, MAO inhibitors (isocarboxazid, linezolid, methylene blue, moclobemide, phenelzine, procarbazine, rasagiline, selegiline, tranylcypromine), other ergot alkaloids (e.g., methysergide), potassium tablets/capsules, pramlintide, sodium oxybate, valproic acid.

Main    A    B    C    D    E    F    G    H    I    J    K    L    M    N    O    P    Q    R    S    T    U    V    W    X    Y    Z    Main